Citigroup’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,000
| Closed | -$639K | – | 5677 |
|
|
2024
Q4 | $639K | Hold |
50,000
| – | – | ﹤0.01% | 3660 |
|
|
2024
Q3 | $557K | Buy |
+50,000
| New | +$551K | ﹤0.01% | 3661 |
|
|
2021
Q1 | – | Sell |
-6,400
| Closed | -$28K | – | 6521 |
|
|
2020
Q4 | $28K | Hold |
6,400
| – | – | ﹤0.01% | 6435 |
|
|
2020
Q3 | $28K | Sell |
6,400
-27,200
| -81% | -$194K | ﹤0.01% | 5955 |
|
|
2020
Q2 | $298K | Sell |
33,600
-5,700
| -15% | -$28.8K | ﹤0.01% | 4709 |
|
|
2020
Q1 | $139K | Sell |
39,300
-14,500
| -27% | -$67.2K | ﹤0.01% | 5055 |
|
|
2019
Q4 | $308K | Buy |
53,800
+15,100
| +39% | +$80.7K | ﹤0.01% | 4827 |
|
|
2019
Q3 | $138K | Buy |
38,700
+31,300
| +423% | +$121K | ﹤0.01% | 5448 |
|
|
2019
Q2 | $30K | Sell |
7,400
-6,700
| -48% | -$38.8K | ﹤0.01% | 6861 |
|
|
2019
Q1 | $103K | Buy |
14,100
+2,600
| +23% | +$25.4K | ﹤0.01% | 5715 |
|
|
2018
Q4 | $105K | Buy |
11,500
+4,400
| +62% | +$48.7K | ﹤0.01% | 5614 |
|
|
2018
Q3 | $88K | Sell |
7,100
-10,600
| -60% | -$143K | ﹤0.01% | 6023 |
|
|
2018
Q2 | $270K | Buy |
17,700
+6,700
| +61% | +$116K | ﹤0.01% | 4747 |
|
|
2018
Q1 | $218K | Sell |
11,000
-3,800
| -26% | -$65.6K | ﹤0.01% | 4878 |
|
|
2017
Q4 | $277K | Sell |
14,800
-12,900
| -47% | -$259K | ﹤0.01% | 4732 |
|
|
2017
Q3 | $596K | Buy |
27,700
+21,500
| +347% | +$340K | ﹤0.01% | 3936 |
|
|
2017
Q2 | $60K | Sell |
6,200
-3,100
| -33% | -$20.1K | ﹤0.01% | 5674 |
|
|
2017
Q1 | $55K | Buy |
9,300
+7,800
| +520% | +$37.5K | ﹤0.01% | 5625 |
|
|
2016
Q4 | $6K | Buy |
+1,500
| New | +$11K | ﹤0.01% | 6870 |
|
Other funds holding DVAX
Citigroup's DVAX Position: Q1 2026 in Review
Citigroup sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 47,601 shares — an estimated $732K sold.
Citigroup first reported a position in DVAX in Q2 2013 and held it in 51 quarters. The position peaked at $15.3M in Q3 2017. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Citigroup reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Citigroup sold 47,601 Dynavax Technologies shares in Q1 2026, an estimated $732K.
- Citigroup first reported a position in Dynavax Technologies in Q2 2013 and held it in 51 quarters.
- Citigroup's Dynavax Technologies position peaked at $15.3M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.